LAC-B
Live / Applied — Non-final action mailed (as of 31 Jan 2026)
What this means for you
Not registered yet, but its 23 Jul 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79437745
- Mark type
- Stylized text
- Filed
- 23 Jul 2025
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cardiovascular disorders and metabolic disorders; pharmaceutical preparations for the treatment of glaucoma and ocular hypertension; pharmaceutical preparations for the treatment of corneal endothelial disorder; sanitary preparations for medical use; pharmaceutical preparations for the treatment of conditions and diseases of the circulatory system; pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; hand-sanitizing preparations; antimicrobials for dermatologic use; disinfectants for sanitary purposes; household disinfectants; pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; pharmaceutical preparations, namely, amino acid for medical or veterinary purposes; pharmaceutical preparations for the prevention and treatment of disorders of the metabolic system; topical and oral antibiotics; pharmaceutical preparations for use in chemotherapy; chemotherapeutic agents having antineoplastic activity; crude drugs, namely, medicines made of rootstock, bark, leaves, fruits, seeds, rhinoceros' horn, musk or bear's gall, used for the treatment of pain, cold, fever, anemia, and for diuretics, astringents; antibiotic preparations for human use; anti-inflammatory agents, namely, topical preparations in the form of gels and salves, adhesive skin patches, liquid formulations, cream and sprays, all for relieving pain; analgesics; dietary supplements for human beings; live biotherapeutic product for medical purposes; biological preparations for medical purposes, namely probiotic preparations
Owner
Prosecution history
- 05 Mar 2026 — CORRECTION TRANSACTION RECEIVED FROM IB
- 19 Feb 2026 — REFUSAL PROCESSED BY IB
- 31 Jan 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 31 Jan 2026 — REFUSAL PROCESSED BY MPU
- 03 Jan 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 02 Jan 2026 — NON-FINAL ACTION WRITTEN
- 17 Dec 2025 — ASSIGNED TO EXAMINER
- 16 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 16 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 15 Dec 2025 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 27 Nov 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB